The role of stem cell therapy in multiple sclerosis: An overview of the current status of the clinical studies
Rokhsareh Meamar1, Shahrzad Nematollahi2, Leila Dehghani1, Omid Mirmosayyeb3, Vahid Shayegannejad4, Keivan Basiri4, Amir Pouya Tanhaei3
1 Department of Medical Sciences, Islamic Azad University, Najafabad Branch, Tehran; Isfahan Neurosciences Research Center, Al Zahra Hospital, Tehran University of Medical Sciences, Tehran, Iran 2 PhD Candidate in Epidemiology, School of Public Health and Institute of Public Health Research, Tehran University of Medical Sciences, Tehran, Iran 3 Isfahan Neurosciences Research Center, Al Zahra Hospital, Tehran University of Medical Sciences, Tehran, Iran 4 Isfahan Neurosciences Research Center, Al Zahra Hospital, Tehran University of Medical Sciences, Tehran; Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran
Date of Submission | 08-Feb-2014 |
Date of Acceptance | 19-Aug-2014 |
Date of Web Publication | 16-Mar-2016 |
Correspondence Address: Dr. Amir Pouya Tanhaei Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan Iran
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2277-9175.178791
The complexity of multiple sclerosis (MS) and the incompetence of a large number of promised treatments for MS urge us to plan new and more effective therapeutic approaches that aim to suppress ongoing autoimmune responses and induction of local endogenous regeneration. Emerging data propose that hematopoietic, mesenchymal, and neural stem cells have the potential to restore self-tolerance, provide in situ immunomodulation and neuroprotection, as well as promote regeneration. Thus, in this article, we will first provide an overview of the cell sources for proposed mechanisms that contribute to the beneficial effects of stem cell transplantation, the ideal route and/or timing of stem cell-based therapies for each main stem cell group, and finally, an overview of the current status of stem cell research in clinical trial stages in MS by comparable and healthy therapeutic effects of different stem cell therapies for MS patients. Keywords: Cell therapy and transplantation, clinical trial, hematopoietic stem cells, mesenchymal stem cells, multiple sclerosis, neural stem/precursor cells, stem cells
How to cite this article: Meamar R, Nematollahi S, Dehghani L, Mirmosayyeb O, Shayegannejad V, Basiri K, Tanhaei AP. The role of stem cell therapy in multiple sclerosis: An overview of the current status of the clinical studies. Adv Biomed Res 2016;5:46 |
How to cite this URL: Meamar R, Nematollahi S, Dehghani L, Mirmosayyeb O, Shayegannejad V, Basiri K, Tanhaei AP. The role of stem cell therapy in multiple sclerosis: An overview of the current status of the clinical studies. Adv Biomed Res [serial online] 2016 [cited 2023 Feb 8];5:46. Available from: https://www.advbiores.net/text.asp?2016/5/1/46/178791 |
This article has been retracted at the request of the Editor-in-Chief, Editorial Board and Authors.

This article has been cited by | 1 |
The need for a strategic therapeutic approach: multiple sclerosis in check |
|
| Hernan Inojosa, Undine Proschmann, Katja Akgün, Tjalf Ziemssen | | Therapeutic Advances in Chronic Disease. 2022; 13: 2040622321 | | [Pubmed] | [DOI] | | 2 |
Human Umbilical Cord Mesenchymal Stem Cells to Treat Neuromyelitis Optica Spectrum Disorder (hUC–MSC–NMOSD): A Study Protocol for a Prospective, Multicenter, Randomized, Placebo-Controlled Clinical Trial |
|
| Xiao-Ying Yao, Li Xie, Yu Cai, Ying Zhang, Ye Deng, Mei-Chun Gao, Yi-Shu Wang, Hui-Ming Xu, Jie Ding, Yi-Fan Wu, Nan Zhao, Ze Wang, Ya-Ying Song, Li-Ping Wang, Chong Xie, Ze-Zhi Li, Wen-Bin Wan, Yan Lin, Hai-Feng Jin, Kan Wang, Hui-Ying Qiu, Lei Zhuang, Yan Zhou, Yu-Yan Jin, Li-Ping Ni, Jia-Li Yan, Quan Guo, Jia-Hui Xue, Bi-Yun Qian, Yang-Tai Guan | | Frontiers in Neurology. 2022; 13 | | [Pubmed] | [DOI] | | 3 |
Therapeutic Effects of Photobiomodulation Therapy on Multiple Sclerosis by Regulating the Inflammatory Process and Controlling Immune Cell Activity: A Novel Promising Treatment Target |
|
| Saeed Vafaei-Nezhad, Somayeh Niknazar, Ali Asghar Payvandi, Atefeh Shirazi Tehrani, Navid Ahmady Roozbahany, Behnaz Ahrabi, Hojjat Allah Abbaszadeh, Shahram Darabi | | Journal of Lasers in Medical Sciences. 2022; 13(1): e32 | | [Pubmed] | [DOI] | | 4 |
A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future |
|
| Mehrdad Gholamzad,Masoumeh Ebtekar,Mehdi Shafiee Ardestani,Maryam Azimi,Zeinab Mahmodi,Mohammad Javad Mousavi,Saeed Aslani | | Inflammation Research. 2019; 68(1): 25 | | [Pubmed] | [DOI] | | 5 |
Mesenchymal stem cells as a treatment for multiple sclerosis: a focus on experimental animal studies |
|
| Ahmed Lotfy,Nourhan S. Ali,Mai Abdelgawad,Mohamed Salama | | Reviews in the Neurosciences. 2019; 0(0) | | [Pubmed] | [DOI] | | 6 |
Various strategies to improve efficacy of stem cell transplantation in multiple sclerosis: Focus on mesenchymal stem cells and neuroprotection |
|
| Forouzan Yousefi,Fahimeh Lavi Arab,Kolsoum Saeidi,Houshang Amiri,Mahmoud Mahmoudi | | Journal of Neuroimmunology. 2018; | | [Pubmed] | [DOI] | | 7 |
Therapeutic Use of Intrathecal Mesenchymal Stem Cells in patients with Multiple Sclerosis: A Pilot Study with Booster Injection |
|
| Mohammad Ali Sahraian,Mandana Mohyeddin Bonab,Seyed Mohammad Baghbanian,Mahsa Owji,Abdorreza Naser Moghadasi | | Immunological Investigations. 2018; : 1 | | [Pubmed] | [DOI] | | 8 |
Emerging Cellular and Molecular Strategies for Enhancing Central Nervous System (CNS) Remyelination |
|
| Mohammad Abu-Rub,Robert Miller | | Brain Sciences. 2018; 8(6): 111 | | [Pubmed] | [DOI] | | 9 |
Cigarette Smoking Impairs Adipose Stromal Cell Vasculogenic Activity and Abrogates Potency to Ameliorate Ischemia |
|
| Daria Barwinska,Dmitry O. Traktuev,Stephanie Merfeld-Clauss,Todd G. Cook,Hongyan Lu,Irina Petrache,Keith L. March | | STEM CELLS. 2018; | | [Pubmed] | [DOI] | | 10 |
Long-term stability and computational analysis of migration patterns of L-MYC immortalized neural stem cells in the brain |
|
| Russell C. Rockne,Vikram Adhikarla,Lusine Tsaturyan,Zhongqi Li,Meher B. Masihi,Karen S. Aboody,Michael E. Barish,Margarita Gutova,Francisco J. Esteban | | PLOS ONE. 2018; 13(8): e0199967 | | [Pubmed] | [DOI] | | 11 |
Methodological aspects of MRI of transplanted superparamagnetic iron oxide-labeled mesenchymal stem cells in live rat brain |
|
| Daria Namestnikova,Ilya Gubskiy,Irina Kholodenko,Pavel Melnikov,Kirill Sukhinich,Anna Gabashvili,Daniil Vishnevskiy,Anastasia Soloveva,Maxim Abakumov,Igor Vakhrushev,Alexei Lupatov,Vladimir Chekhonin,Leonid Gubsky,Konstantin Yarygin,Johannes Boltze | | PLOS ONE. 2017; 12(10): e0186717 | | [Pubmed] | [DOI] | | 12 |
Metabolic pathways as possible therapeutic targets for progressive multiple sclerosis |
|
| RebeccaM Heidker,MitchellR Emerson,StevenM LeVine | | Neural Regeneration Research. 2017; 12(8): 1262 | | [Pubmed] | [DOI] | | 13 |
Yin and Yang of mesenchymal stem cells and aplastic anemia |
|
| Larisa Broglie,David Margolis,Jeffrey A Medin | | World Journal of Stem Cells. 2017; 9(12): 219 | | [Pubmed] | [DOI] | | 14 |
A New Chapter for Mesenchymal Stem Cells: Decellularized Extracellular Matrices |
|
| Yagiz Anasiz,Riza Koksal Ozgul,Duygu Uckan-Cetinkaya | | Stem Cell Reviews and Reports. 2017; | | [Pubmed] | [DOI] | | 15 |
CNS disease diminishes the therapeutic functionality of bone marrow mesenchymal stem cells |
|
| Alex Sargent,Lianhua Bai,Genevieve Shano,Molly Karl,Eric Garrison,Lahiru Ranasinghe,Sarah M. Planchon,Jeffrey Cohen,Robert H. Miller | | Experimental Neurology. 2017; 295: 222 | | [Pubmed] | [DOI] | | 16 |
Organotypic cultures of cerebellar slices as a model to investigate demyelinating disorders |
|
| Frédéric Doussau,Jean-Luc Dupont,Dorine Neel,Aline Schneider,Bernard Poulain,Jean Louis Bossu | | Expert Opinion on Drug Discovery. 2017; : 1 | | [Pubmed] | [DOI] | | 17 |
Stem cells and other emerging agents as innovative “drugs” in neurodegenerative diseases: benefits and limitations |
|
| Martina Nasello,giuseppe schirò,Floriana Crapanzano,CARMELA RITA BALISTRERI | | Rejuvenation Research. 2017; | | [Pubmed] | [DOI] | | 18 |
Anti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL-37 |
|
| Sabrina Giacoppo,Soundara Rajan Thangavelu,Francesca Diomede,Placido Bramanti,Pio Conti,Oriana Trubiani,Emanuela Mazzon | | The FASEB Journal. 2017; 31(12): 5592 | | [Pubmed] | [DOI] | | 19 |
Stemness Characteristics of Periodontal Ligament Stem Cells from Donors and Multiple Sclerosis Patients: A Comparative Study |
|
| Francesca Diomede,Thangavelu Soundara Rajan,Marco D’Aurora,Placido Bramanti,Ilaria Merciaro,Marco Marchisio,Valentina Gatta,Emanuela Mazzon,Oriana Trubiani | | Stem Cells International. 2017; 2017: 1 | | [Pubmed] | [DOI] | | 20 |
The future of multiple sclerosis treatments |
|
| Catalina Coclitu,Cris S. Constantinescu,Radu Tanasescu | | Expert Review of Neurotherapeutics. 2016; 16(12): 1341 | | [Pubmed] | [DOI] | | 21 |
Taking Advantage of Nature’s Gift: Can Endogenous Neural Stem Cells Improve Myelin Regeneration? |
|
| Rainer Akkermann,Janusz Jadasz,Kasum Azim,Patrick Küry | | International Journal of Molecular Sciences. 2016; 17(11): 1895 | | [Pubmed] | [DOI] | |
|
 |
 |
|